Depo Provera Leads
Reach women who developed meningioma or other intracranial tumors after receiving medroxyprogesterone acetate (Depo Provera) injections for contraception.
Depo Provera Litigation
Depo Provera is an injectable contraceptive containing medroxyprogesterone acetate, manufactured by Pfizer. Recent studies have established a strong association between prolonged Depo Provera use and an increased risk of developing meningioma, a type of brain tumor that forms on the membranes surrounding the brain and spinal cord. Lawsuits allege the manufacturer knew or should have known about this risk and failed to provide adequate warnings to patients and healthcare providers.
Associated Conditions
- Meningioma (brain tumors)
- Intracranial tumors
- Headaches and vision changes
- Seizures
- Neurological impairment
- Surgical intervention for tumor removal
- Hearing loss or cognitive decline
Claimant Eligibility
- Received Depo Provera injections for one year or longer
- Diagnosed with meningioma or intracranial tumor
- Tumor diagnosis occurred during or after Depo Provera use
- Required surgery, radiation, or ongoing monitoring for the tumor
- Medical records confirming Depo Provera prescription history
Why Law Firms Choose Us
Exclusive Leads
Every lead is yours alone. We never resell or share claimant information with competing firms, guaranteeing you first-mover advantage on every case.
Pre-Qualified Claimants
Our intake specialists screen every potential claimant against your specific case criteria before delivery, so your team only speaks with viable cases.
Live Transfer
Qualified claimants are transferred directly to your intake team in real time, maximizing conversion rates and reducing time-to-retainer.
Ready to Scale Your Mass Tort Practice?
Tell us about your firm and a mass tort strategist will reach out within one business day.
Trusted by 200+ law firms nationwide